This article discusses genetics-related policy issues that have an impact on health care systems, health care providers, and their patients: privacy, mass screening, family screening, and knowledge dissemination. Access, cost, and ethical implications are important discussant points for each of these genetic-related policy issues. Embedded in the issue of privacy are concerns of insurability, confidentiality, and discrimination. The public health policy implications related to mass screening programs include efficacy of the screening tests, availability of primary and secondary interventions, access, costs, and program evaluation. Policy issues for family screening are similar to mass screening, with added concerns about privacy and availability of adequate resources, including health care providers and counselors trained in genetics. Knowledge dissemination is critical to maintaining currency of clinical information and applications of genetic technologies and treatments. As genetic information expands, the need for knowledge dissemination will increase. The importance of advanced practice nurses’ involvement in these policy issues is discussed.
American Academy of Pediatrics, Committee on Bioethics. (2001). Ethical issues with genetic testing in pediatrics. Pediatrics, 107(6), 1451-1455.
2.
Association of Professors of Human and Medical Genetics/American Society of Human Genetics. (1995). Medical school core curriculum in genetics. American Journal of Human Genetics, 56, 535-537.
3.
Association of Professors of Human and Medical Genetics/American Society of Human Genetics. (2003). Medical school core curriculum in genetics. Retrieved November 26, 2003, from http://genetics.faseb.org/genetics/ashg/policy/rep-01.htm
4.
Baroni, M. A., Anderson, Y. E., & Mischler, E. (1997). Cystic fibrosis newborn screening: Impact of early screening results on parenting stress. Pediatric Nursing, 23(2), 143-151.
5.
Burke, W. (2002). Genetic testing. New England Journal of Medicine, 347(23), 1867-1875.
6.
Burke, W., Coughlin, S. S., Lee, N. C., Weed, D. L., & Khoury, M. J. (2001). Application of population screening principles to genetic screening for adult-onset conditions. Genetic Testing, 5(3), 201-211.
7.
Calzone, K. (2000). Genetics and nursing education and practice: Activities and federal programmatic recommendations. In Report of the expert panel on genetics and nursing: Implications for education and practice. Rockville, MD: Human Resources and Services Administration.
8.
Centers for Disease Control. (1997). Newborn screening for cystic fibrosis: A paradigm for public health genetics policy development proceedings of a 1997 workshop. Morbidity and Mortality Weekly Report, 46(RR16), 1-22.
9.
Centers for Medicare and Medicaid Services. (2004). HIPAA insurance reform. Retrieved October 26, 2004, from www.cms.hhs.gov/hipaa/hipaa1/content
10.
Day, S. W., Brunson, G. E., & Wang, W. C. (1997). Successful newborn sickle cell trait counseling program using health department nurses. Pediatric Nursing, 23(6), 557-561.
11.
Genetic Information and Nondiscrimination Act of 2003 (Senate bill S.1053). Retrieved October 23, 2003, from http://thomas.loc.gov/cgi-bin/query/D?c108:1:./temp/%7Ec108Cfmzrt
12.
Glaxo Smith Kline. (2003). Basic human genetics eLearning programme [CD-ROM]. Research Triangle Park, NC: Author.
13.
Guttmacher, A. E., & Collins, F. S. (2002). Genomic medicine—A primer. New England Journal of Medicine, 347(19), 1512-1520.
14.
Hall, M. A., & Rich, S. R. (2000). Genetic privacy laws and patients’ fear of discrimination by health insurers: The view from genetic counselors. Journal of Law, Medicine & Ethics, 28(3), 245-257.
15.
Human Genome Program. (2003). Genetics privacy and legislation. Retrieved October 23, 2003 from http://www.ornl.gov/sci/techresources/Human_Genome/elsi/legislat.shtml
16.
Hustead, J. L., Cunningham, A., & Goldman, J. (2002, April). Genetics and privacy: A patchwork of protections. Retrieved October 23, 2003, from http://www.chcf.org/topics/view.cfm?itemID=19759
17.
Johnson, A. (2002a, June). Genetic privacy. Genetics Brief, 6, 1.
18.
Johnson, A. (2002b, June). Genetics and health insurance. Genetics Briefs, 7, 1.
19.
Jung, B., & Carethers, J. M. (2003). Screening for colorectal cancer: Analysis of evidence and cost-effectiveness. Journal of Clinical Outcomes Management, 10(2), 87-94.
20.
Kavalier, F., & Kent, A. (2003). Genetics and the general practitioner: White paper takes the first steps down a long road [editorial]. (2003). British Medical Journal, 327, 2-3.
21.
Khoury, M. J., McCabe, L. L., & McCabe, E. R. B. (2003). Population screening in the age of genomic medicine. New England Journal of Medicine, 348(1), 50-58.
22.
Kumar, S., & Gantley, M. (1999). Tensions between policy makers and general practitioners in implementing new genetics: Grounded theory interview study. British Medical Journal, 319(7222), 1410-1413.
23.
Lashley, F. (1998). Clinical genetics in nursing practice (2nd ed.). New York: Springer.
24.
Lynch, H. T., & Chapelle, A. (2003). Hereditary Colorectal Cancer. New England Journal of Medicine, 348(10), 919-932.
25.
March of Dimes. (2004, October 26). Genetics and your practice. Retrieved October 26, 2004, from http://www.marchofdimes.com/gyponline/index.bm2
26.
Mason, D., Leavitt, J., & Chaffee, M. (2002). Policy and politics in nursing and health care (4th ed.). New York: Saunders-Elsevier.
27.
Milstead, J. (2004). Health policy and politics: A nurse’s guide (2nd ed.). Boston: Jones & Bartlett.
28.
Mountcastle-Shah, E., & Holtzman, N. A. (2000). Primary care physicians’ perceptions of barriers to genetic testing and their willingness to participate in research. American Journal of Medical Genetics, 94, 409-416.
29.
National Coalition for Health Professional Education in Genetics. (2000a, February 14). Core competencies in genetics: Essential for all health-care professionals. Retrieved February 2, 2004, from http://www.nchpeg.org/nchpeg.html?http://www.nchpeg.org/eduresources/core/main.asp
30.
National Coalition for Health Professional Education in Genetics. (2000b, February 14). Remedica genetics series. Retrieved February 2, 2004, from http://www.nchpeg.org/eduresources/clearinghouse.asp
31.
National Human Genome Research Institute. (2004). Summary of Genetic Information Non-discrimination Act of 2003. Retrieved: February 2, 2004 from http://www.genome.gov/11508845
32.
National Institutes of Health. (1997). Genetic testing for cystic fibrosis. Consensus Statements, 15(4). Retrieved October 26, 2004, from http://consensus.nih.gov/cons/106/106_intro.htm
33.
Nussbaum, R., McInnes, R., & Huntington, F. (2004). Genetics in medicine, sixth edition. New York: Saunder-Elsevier.
34.
Pagon, R. A., Tarczy-Hornoch, P., Baskin, P. K., Edwards, J. E., Covington, M. L., Espeseth, M., et al. (2002). GeneTests-GeneClinics: Genetic testing information for a growing audience. Human Mutation, 19(5), 501-509.
35.
Rex, D. (2001). Colorectal cancer screening and surveillance: the present and the future. Reviews in Gastroenterologicical Disorders, 1(1), 18-31.
36.
Rothstein, M. A., & Hoffman, S. (1999). Genetic testing, genetic medicine, and managed care. Wake Forest Law Review, 34(3), 849-888.
37.
Williams, M. S. (2001). Genetics and managed care: Policy statement of the American College of Medical Genetics. Genetics in Medicine, 3(6), 430-435.
38.
Yoon, P. W., Chen, B., Faucett, A., Clyne, M., Gwinn, M., Lubin, I. M., et al. (2001). Public health impact of genetic tests at the end of the 20th century. Genetics in Medicine, 3(6), 405-410.
39.
Zweig, F. M., & Davis, A. M. (2000). Genetic technologies and courts of law. Community Genetics, 3(4), 215-220.
40.
Bernhardt, B. A., Biesecker, B. B., & Mastromarino, C. L. (2000). Goals, benefits, and outcomes of genetic counseling: Client and genetic counselor assessment. American Journal of Medical Genetics, 94(3), 189-197.
41.
Elsas, L., & Trepanier, A. (2000). Cancer genetics in primary care. Postgraduate Medicine, 107(4), 191-208.
42.
Greco, K. E. (2003). Nursing in the genomic era: Nurturing our genetic nature. Medsurg Nursing, 12(5), 307-312.
43.
Harman, L. B. (2003). Attitudes toward genetic testing: Gender, role, and discipline. Topics in Health Information Management, 24(1), 50-58.
44.
Levitt, M. (2003). Public consultation in bioethics: What’s the point of asking the public when they have neither scientific nor ethical expertise?Health Care Analysis, 11(1), 15-25.
45.
Reilly, P.R. (1997). Fear of genetic discrimination drives legislative interest. Human Genome News, 8, 3-4.
46.
Wideroff, L., Freedman, A. N., Olson, L., Klabunde, C. N., Davis, W., Srinath, K. P., et al. (2003). Physician use of genetic testing for cancer susceptibility: Results of a national survey. Cancer Epidemiology Biomarkers & Prevention, 12(4), 295-303.
